COMP <GO>
IREN vs CORZ // RETURN ON INVESTED CAPITAL (ROIC)
IREN Limited (NASDAQ) VS. Core Scientific Inc. (NASDAQ) • 15-METRIC TALLY: IREN 7
— CORZ 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: IREN
LAST: $21.71 (-11.24%) • MKT CAP: $8.91B
roic
1.20%
LAST: $12.76 (-10.39%) • MKT CAP: $4.02B
roic
-35.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IREN VS. CORZ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IREN | CORZ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 1.20% | -35.00% | +36.20 | IREN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.08% | -9.72% | +6.64 | IREN | /fcf-yield <GO> |
| Operating Margin | 3.50% | -60.00% | +63.50 | IREN | /operating-margins <GO> |
| Net Profit Margin | 17.40% | -60.00% | +77.40 | IREN | /net-margins <GO> |
| Revenue Growth (YoY) | 167.70% | -37.50% | +205.20 | IREN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 5/9 | +3.00 | IREN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 30.5 | 37.5 | -7.00 | CORZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.12 | -0.04 | CORZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 102.6x | 29.0x | +73.60 | CORZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $8.91B | $4.02B | $4.89B | IREN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IREN REV | CORZ REV | IREN GROSS % | CORZ GROSS % | IREN FCF | CORZ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $501.0M | $319.0M | 68.3% | 11.9% | -$327.6M | -$450.8M |
| FY 2024 | $187.2M | $510.7M | 53.5% | 23.7% | -$89.6M | -$52.1M |
| FY 2023 | $75.5M | $502.4M | — | — | $2.3M | $42.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IREN // BETA 1.08
CORZ // BETA 1.12